Structure of PDB 6ww0 Chain D |
>6ww0D (length=467) Species: 9606 (Homo sapiens) [Search protein sequence] |
SLLSLPLVGSLPFLPRHGHMHNNFFKLQKKYGPIYSVRMGTKTTVIVGHH QLAKEVLIKKGKDFSGRPQMATLDIASNNRKGIAFADSGAHWQLHRRLAM ATFALFKDGDQKLEKIICQEISTLCDMLATHNGQSIDISFPVFVAVTNVI SLICFNTSYKNGDPELNVIQNYNEGIIDNLSKDSLVDLVPWLKIFPNKTL EKLKSHVKIRNDLLNKILENYKEKFRSDSITNMLDTLMQAKMNSDDSELL SDNHILTTIGDIFGAGVETTTSVVKWTLAFLLHNPQVKKKLYEEIDQNVG FSRTPTISDRNRLLLLEATIREVLRLRPVAPMLIPHKANVDSSIGEFAVD KGTEVIINLWALHHNEKEWHQPDQFMPERFLNPAGTQLISPSVSYLPFGA GPRSCIGEILARQELFLIMAWLLQRFDLEVPDDGQLPSLEGIPKVVFLID SFKVKIKVRQAWREAQA |
|
PDB | 6ww0 Human cytochrome P450 17A1 structures with metabolites of prostate cancer drug abiraterone reveal substrate-binding plasticity and a second binding site. |
Chain | D |
Resolution | 2.01 Å |
3D structure |
|
|
Catalytic site (original residue number in PDB) |
T306 F435 C442 |
Catalytic site (residue number reindexed from 1) |
T269 F398 C405 |
Enzyme Commision number |
1.14.14.19: steroid 17alpha-monooxygenase. 1.14.14.32: 17alpha-hydroxyprogesterone deacetylase. |
|
|
|
|